Bausch Health (LTS:0QYW) Accounts Payable: CHF474 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QYW Bausch Health Companies Inc LTS:0QYW
65 GF Score
Price CHF122.94
GF Value CHF157.98
! 3 Warning Signs
View Full Analysis

What is Bausch Health Accounts Payable?

Bausch Health LTS:0QYW 65 Accounts Payable is CHF474 Mil as of Jun. 2026. GuruFocus rates LTS:0QYW with a GF Score™ of 65/100 and a GF Value™ of CHF157.98. The stock has 3 warning signs investors should review.

Bausch Health's Accounts Payable for the quarter that ended in Jun. 2026 was CHF474 Mil.

Bausch Health's quarterly Accounts Payable declined from Dec. 2025 (CHF478 Mil) to Mar. 2026 (CHF467 Mil) but then increased from Mar. 2026 (CHF467 Mil) to Jun. 2026 (CHF474 Mil).

Bausch Health's annual Accounts Payable declined from Dec. 2023 (CHF622 Mil) to Dec. 2024 (CHF525 Mil) and declined from Dec. 2024 (CHF525 Mil) to Dec. 2025 (CHF478 Mil).

Bausch Health Accounts Payable Related Terms

Bausch Health Accounts Payable Historical Data

* Premium members only.

The historical data trend for Bausch Health's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health Accounts Payable Chart

Bausch Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 374.85 485.36 621.79 525.15 478.14

Bausch Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 509.88 490.40 478.14 466.87 473.99
LTS:0QYW
65GF Score
Bausch Health Companies Inc LTS:0QYW
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch Health Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of CHF474 Mil mean?
Bausch Health (LTS:0QYW) has a Accounts Payable of CHF474 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Bausch Health and its competitors.
Is Bausch Health's Accounts Payable too high?
Bausch Health's current Accounts Payable is CHF474 Mil. Overall, Bausch Health has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's Accounts Payable compare to ZTS?
Bausch Health's Accounts Payable of CHF474 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Bausch Health and its competitors. Bausch Health's current Accounts Payable is CHF474 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Bausch Health (LTS:0QYW) has a current Accounts Payable of CHF474 Mil. The stock's GF Value™ is CHF157.98, compared to a current price of CHF122.94 — trading 22.2% below its estimated fair value. The current Accounts Payable is CHF474 Mil. Bausch Health's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Bausch Health (LTS:0QYW), the current Accounts Payable is CHF474 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch Health (LTS:0QYW) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of CHF122.94 is trading 22.2% below its estimated GF Value™ of CHF157.98.

Key valuation signals for LTS:0QYW:

  • Accounts Payable: CHF474 Mil
  • GF Value™: CHF157.98 vs. price of CHF122.94 (22.2% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the LTS:0QYW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
65GF Score

Get the complete analysis for LTS:0QYW

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF122.94
Price
CHF157.98
GF Value